Global Cardiovascular Health Supplements Market Report 2024

The cardiovascular health supplements market size has grown rapidly in recent years. It will grow from $11.67 billion in 2023 to $13.11 billion in 2024 at a compound annual growth rate (CAGR) of 12.3%. The historical growth can be attributed to several factors, including the shift towards less invasive surgical techniques, the increasing demand for structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, and heightened awareness of heart health.

The cardiovascular health supplements market size is expected to see rapid growth in the next few years. It will grow to $20.98 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, and timely regulatory approvals. Major trends expected in the forecast period encompass increased collaboration among stakeholders, utilization of real-world evidence, product launches, emphasis on preventive interventions, and ongoing innovations in the field.

The rising prevalence of heart-related diseases is poised to drive the expansion of the cardiovascular health supplements market in the foreseeable future. Heart-related diseases, also termed cardiovascular diseases (CVD), encompass a range of conditions impacting the heart and blood vessels. Contributing factors to the increasing prevalence of these diseases include insufficient physical activity, poor dietary habits, smoking, and chronic stress. Cardiovascular health supplements comprise ingredients and nutrients aimed at supporting heart function, particularly in individuals with heart failure or other cardiac conditions. For example, as reported by the British Heart Foundation in April 2023, Scotland witnessed a rise in deaths from all heart and circulatory illnesses, totaling 17,639 in 2021 compared to 17,448 in 2020. Similarly, the UK experienced an increase in deaths from coronary heart disease, reaching 65,579 in 2021 compared to 64,170 in 2020. Hence, the heightened prevalence of heart-related diseases propels the cardiovascular health supplements market forward.

Key players in the cardiovascular health supplements industry are directing their efforts towards offering novel natural plant-based products containing ingredients such as dispersible phytosterols, aimed at lowering cholesterol levels and gaining a competitive advantage. Dispersible phytosterols denote a form of plant sterols engineered to readily disperse or dissolve in water, aiding in cholesterol reduction within the body and targeting cardiovascular health. For instance, in September 2023, Nutrartis, a Chile-based health solutions provider, introduced Cardiosmile, a supplement crafted with natural plant sterols. Cardiosmile, available in liquid form, features water-dispersible phytosterols that contribute to cholesterol management and daily heart wellness. Its clinical efficacy lies in its ability to diminish cholesterol absorption, thereby supporting systemic heart and metabolic health while assisting in maintaining healthy cholesterol levels.

In September 2023, Sanofi, a France-based pharmaceutical industry leader, acquired Qunol for an undisclosed sum. This acquisition aimed to bolster Sanofi's consumer healthcare (CHC) and vitamin, mineral, and supplements (VMS) segment, one of the most expansive and rapidly growing consumer health sectors in the United States. Qunol, a US-based healthcare enterprise, specializes in offering a variety of cardiovascular health supplements tailored to the needs of the aging population.

Major companies operating in the cardiovascular health supplements market are Pfizer Inc., Johnson & Johnson, Amway Corporation, Herbalife Nutrition Ltd., General Nutrition Centers Inc. (GNC), NOW Health Group Inc., Garden of Life LLC, Thorne Healthtech Inc., Jarrow Formulas Inc., Life Extension, Designs for Health Inc., Gaia Herbs Inc., Schiff Nutrition International, MegaFood LLC, Twinlab Consolidated Holdings Inc., New Chapter Inc., Integrative Therapeutics LLC, Pure Encapsulations LLC, Doctor's Best Inc., Nature's Bounty Co., Solgar Inc., Renew Life Formulas LLC, Nature Made Nutritional Products, Source Naturals Inc.

Asia-Pacific was the largest region in the cardiovascular health supplements market in 2023. The regions covered in the cardiovascular health supplements market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular health supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cardiovascular health supplements are dietary products designed to promote the health and functionality of the heart and blood vessels. They are commonly utilized to support heart health and prevent or manage various cardiovascular conditions.

The primary types of cardiovascular health supplements include natural and synthetic variants. Natural supplements are derived from sources such as plants, animals, and minerals, and typically comprise ingredients such as vitamins and minerals, herbs and botanicals, omega fatty acids, coenzyme Q10 (CoQ10), among others. These supplements are available in various forms such as liquid, tablets, capsules, softgels, and powders, and are distributed through channels including offline and online.

The cardiovascular health supplements market research report is one of a series of new reports that provides cardiovascular health supplements market statistics, including the cardiovascular health supplements industry global market size, regional shares, competitors with cardiovascular health supplements market share, detailed cardiovascular health supplements market segments, market trends, and opportunities, and any further data you may need to thrive in the cardiovascular health supplements industry. These cardiovascular health supplements market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiovascular health supplements market consists of sales of fiber supplements, garlic supplements, and magnesium. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.